NULISAseq Neuro 220 Panel
Neurological Disease Research (Alzheimer's, Parkinson's)
RUOActive
Key Facts
Indication
Neurological Disease Research (Alzheimer's, Parkinson's)
Phase
RUO
Status
Active
Company
About Alamar Biosciences
Alamar Biosciences is a private, precision proteomics company building a vertically integrated platform (ARGO instrument, NULISA consumables, software) for ultra-sensitive, multiplex protein detection. The company is targeting the high-growth biomarker discovery and early disease detection market, with a strong initial focus on neurological conditions like Alzheimer's and Parkinson's disease. Backed by notable investors and led by a seasoned team with experience in proteomics, diagnostics, and scaling biotech companies, Alamar is transitioning from platform development to commercial launch of its research-use-only products.
View full company profile